Developmental Context Determines Latency of MYC-Induced Tumorigenesis
Open Access
- 28 September 2004
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Biology
- Vol. 2 (11), e332
- https://doi.org/10.1371/journal.pbio.0020332
Abstract
One of the enigmas in tumor biology is that different types of cancers are prevalent in different age groups. One possible explanation is that the ability of a specific oncogene to cause tumorigenesis in a particular cell type depends on epigenetic parameters such as the developmental context. To address this hypothesis, we have used the tetracycline regulatory system to generate transgenic mice in which the expression of a c-MYC human transgene can be conditionally regulated in murine hepatocytes. MYC's ability to induce tumorigenesis was dependent upon developmental context. In embryonic and neonatal mice, MYC overexpression in the liver induced marked cell proliferation and immediate onset of neoplasia. In contrast, in adult mice MYC overexpression induced cell growth and DNA replication without mitotic cell division, and mice succumbed to neoplasia only after a prolonged latency. In adult hepatocytes, MYC activation failed to induce cell division, which was at least in part mediated through the activation of p53. Surprisingly, apoptosis is not a barrier to MYC inducing tumorigenesis. The ability of oncogenes to induce tumorigenesis may be generally restrained by developmentally specific mechanisms. Adult somatic cells have evolved mechanisms to prevent individual oncogenes from initiating cellular growth, DNA replication, and mitotic cellular division alone, thereby preventing any single genetic event from inducing tumorigenesis.Keywords
This publication has 72 references indexed in Scilit:
- Suppression of Myc-Induced Apoptosis in β Cells Exposes Multiple Oncogenic Properties of Myc and Triggers Carcinogenic ProgressionCell, 2002
- The evolution of diverse biological responses to DNA damage: insights from yeast and p53Nature Cell Biology, 2001
- Reversible Activation of c-Myc in SkinMolecular Cell, 1999
- Regulation ofp53downstream genesSeminars in Cancer Biology, 1998
- Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4aCell, 1997
- Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.Proceedings of the National Academy of Sciences, 1996
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992
- Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumoursNature, 1990
- COMPARISON OF IN VIVO AND IN VITRO IMMUNE RESPONSE TO PURIFIED HEPATOCYTESTransplantation, 1990
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985